528 results
8-K
EX-99.1
TEVA
Teva- Pharmaceutical Industries Ltd.
8 May 24
Teva Reports First Quarter 2024 Financial Results and Reaffirms 2024 Financial Outlook
7:01am
manufacturing footprint to enable strategic capital deployment to accelerate our near and long-term growth engines and reorganizing certain of our … obligations
Accrued expenses
Other current liabilities
Liabilities hels for sale
Total current liabilities
Long-term liabilities:
Deferred income taxes
8-K
EX-99.1
pdga1nmbhle t9
31 Jan 24
Results of Operations and Financial Condition
7:00am
8-K
EX-99.1
rfcyk7c
8 Nov 23
2023 revenues outlook revised to $15.1 - $15.5 billion from $15.0 - $15.4 billion
7:01am
8-K
EX-99.1
o50je8d8 ha9f11thg
2 Aug 23
Results of Operations and Financial Condition
7:00am
8-K
EX-99.1
qelkt
10 May 23
Results of Operations and Financial Condition
7:01am
8-K
EX-99.1
9kdaesm
21 Nov 22
Teva Announces Appointment of Richard Francis as President and CEO
7:00am
8-K
EX-99.1
mw84ri c0c305m
3 Nov 22
Key financial highlights and outlook
7:00am
8-K
EX-99.1
qrxp0ho
26 Jul 22
Key financial highlights and outlook
4:56pm